This clinical-stage biotech develops innovative retinal disease therapies, with its lead candidate advancing through ...

Age-related macular degeneration is a common cause of blindness, but adding some static noise to a patient’s vision can ...

4D Molecular Therapeutics (NASDAQ:FDMT) executives said the company is seeing strong clinical trial momentum for its lead ...

An expert MD reveals clear insights into cataract surgery, spotlighting the breakthroughs in treatment: "We live in a time of miracle and wonder." The post “What I Wish I’d Known About Cataract ...

Belite Bio, Inc. (NASDAQ: BLTE), (“Belite Bio®” or the “Company”), a clinical-stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal ...

EyePoint said on Thursday an independent safety committee found no new concerns in ​two late-stage trials of its experimental eye disease drug ‌Duravyu and recommended the studies continue unchanged.

Healthy Vision Month in May is a great time for Texans to focus on protecting their vision health and preventing eye disease. To keep eyes healthy, schedule regular eye exams to check for common ...

LUGANO topline data on track for mid-2026, with LUCIA readout to follow shortly after – – Continued favorable safety profile observed in masked ...

According to the Centers for Disease Control and Prevention, an estimated 93 million American adults are at high risk for ...

Aims To evaluate whether predominantly peripheral lesions (PPLs) and other imaging biomarkers on ultra-widefield (UWF) ...

Researchers have identified distinct biological features linked to a high risk of developing a severe form of age-related ...

In an observational claims database, patients using GLP-1 receptor agonists (GLP-1RAs) had significantly lower risk of ...